© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Gastroenterology
SER-287 Shows Efficacy in Treating Ulcerative Colitis in Early Phase Trial
August 05, 2020
Article
Firmicutes bacteria can help produce metabolites that maintain intestinal barriers and mucosal immunity.
Irritable Bowel Syndrome Rates Might Be Lower Than Previously Thought
August 03, 2020
Article
There is a higher prevalence of IBS found in women than men.
Miguel Regueiro, MD: Ongoing Examination at Link Between Gastrointestinal Symptoms and COVID-19
July 31, 2020
Article
Nearly two-thirds of COVID-19 patients have gastrointestinal symptoms.
FDA Expands Ustekinumab to Pediatric Plaque Psoriasis
July 31, 2020
Article
The expansion makes history for the injection biologic.
Direct-Acting Antivirals Lowers Mortality Rate of Hepatitis C Infections
July 22, 2020
Article
The association of DAA treatment with mortality did not differ by sex in the cirrhosis group.
Risk Factor Score Could Reduce Gastrointestinal Bleeding Hospitalizations
July 19, 2020
Article
New scoring model is based on an eight-point threshold to accurately predict patients at a low risk of adverse outcomes.
FDA Committee Signs Off on Terlipressin for HRS-1
July 16, 2020
Article
The 8-7 decision allows Mallinckrodt to move forward with a Sept. 12 PDUFA date for the investigational agent.
Multidisciplinary Approach Beneficial for Functional Gastrointestinal Disorders
July 16, 2020
Article
Patients in the multidisciplinary-care group were more likely to experience a 50% or higher reduction in all Gastrointestinal Symptom Severity Index symptom clusters than the patients who were in the standard-care group.
Laparoscopic Ileocecal Resection Comparable to Anti-TNF's for Crohn's Disease
July 10, 2020
Article
In a sample of patients treated with laparoscopic ileocecal resection, 42% (n = 29) of patients did not require additional Crohn’s disease-related medication, while 48% (n = 14) were given prophylactic immunomodulator therapy.
Certain Fecal Fungal Microbiome Patterns Found in COVID-19 Patients
July 01, 2020
Article
The diversity of the fecal mycobiome of the last sample collected was 2.5-fold higher in COVID-19 patients than it was in the control group.